HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Madhi Saranadasa Selected Research

Chromatin

8/2011Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Madhi Saranadasa Research Topics

Disease

2Neoplasms (Cancer)
08/2011 - 02/2011

Drug/Important Bio-Agent (IBA)

1ChromatinIBA
08/2011
1Sunitinib (Sutent)FDA Link
02/2011
1Tyrosine Kinase InhibitorsIBA
02/2011
1Phosphotransferases (Kinase)IBA
02/2011
1Biomarkers (Surrogate Marker)IBA
02/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2011
1Bevacizumab (Avastin)FDA Link
02/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011
1Sorafenib (BAY 43-9006)FDA Link
02/2011

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2011
1Therapeutics
02/2011